Skip to main content

CR

Crack GPAT — Prepare for GPAT Online 
  • ICON Plc (Chennai) requires Drug Safety Associates

    ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies

    Post:Drug Safety Associate

  • LCT gets approval to advance to phase-II human trial with Diabecell

    Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received approval to advance to the next phase of its New Zealand phase-II human clinical trial with its groundbreaking Diabecell. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its Diabecell implants.

  • Deaths during clinical trials on rise as India turning as hot destination

    Even as the dust is yet to settle down over the HPV vaccine trial and death of three tribal girls in Andhra Pradesh, records showed that the total number of deaths among the clinical trial subjects, though not officially termed as part of the trials, are on the increase in India.

  • Several drugs to come under regulatory scanner as national pharmacovigilance programme to begin in April

    Two H1N1 drugs - oseltamivir and zanamavir, the controversial sub-fertility drug letrozole, popular non-steroidal anti-inflammatory drug nimesulide, decongestant drug phenylpropanolamine (PPA), antibiotic drug gatifloxacine, chronic constipation drug tegaserod, type-2 diabetes drug pioglitazone and rosiglitazone have been selected for the first phase of national pharmacovigilance programme which will begin in select 40 medical colleges across the country from April this year.

  • Senior Clin Ops Manager - Philippines at Resourse Scientific

    Resourse Scientific

    Senior Clin Ops Manager - Philippines

  • MakroCare to organise Webinar on Late Phase (PMS & IIT) on March 5

    MakroCare, a global clinical services firm which provides clinical research support to pharmaceutical, biotechnology and medical devices industries will be organising an interactive “Webinar on Late Phase (PMS and IIT) – Opportunities and Challenges” on March 5, 2010 at Makro Tower, Hyderabad from 3.00 p.m. to 04.30 p.m.

Subscribe to CR